Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength

Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isofor...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of physiology: endocrinology and metabolism Vol. 306; no. 8; pp. E965 - E974
Main Authors Brisson, Becky K, Spinazzola, Janelle, Park, SooHyun, Barton, Elisabeth R
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 15.04.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isoforms is identical yet the E-peptides, EA and EB, share less than 50% homology. Recent in vitro studies show that the E-peptides can enhance IGF-I signaling, leading to increased myoblast cell proliferation and migration. To determine the significance of these actions in vivo and to evaluate if they are physiologically beneficial, EA and EB were expressed in murine skeletal muscle via viral vectors. The viral constructs ensured production of E-peptides without the influence of additional IGF-I through an inactivating mutation in mature IGF-I. E-peptide expression altered ERK1/2 and Akt phosphorylation and increased satellite cell proliferation. EB expression resulted in significant muscle hypertrophy that was IGF-I receptor dependent. However, the increased mass was associated with a loss of muscle strength. EA and EB have similar effects in skeletal muscle signaling and on satellite cells, but EB is more potent at increasing muscle mass. Although sustained EB expression may drive hypertrophy, there are significant physiological consequences for muscle.
AbstractList Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isoforms is identical yet the E-peptides, EA and EB, share less than 50% homology. Recent in vitro studies show that the E-peptides can enhance IGF-I signaling, leading to increased myoblast cell proliferation and migration. To determine the significance of these actions in vivo and to evaluate if they are physiologically beneficial, EA and EB were expressed in murine skeletal muscle via viral vectors. The viral constructs ensured production of E-peptides without the influence of additional IGF-I through an inactivating mutation in mature IGF-I. E-peptide expression altered ERK1/2 and Akt phosphorylation and increased satellite cell proliferation. EB expression resulted in significant muscle hypertrophy that was IGF-I receptor dependent. However, the increased mass was associated with a loss of muscle strength. EA and EB have similar effects in skeletal muscle signaling and on satellite cells, but EB is more potent at increasing muscle mass. Although sustained EB expression may drive hypertrophy, there are significant physiological consequences for muscle. [PUBLICATION ABSTRACT]
Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a COOH-terminal extension called the E-peptide. Alternative splicing in the rodent produces two isoforms, IA and IB, where the mature IGF-I in both isoforms is identical yet the E-peptides, EA and EB, share less than 50% homology. Recent in vitro studies show that the E-peptides can enhance IGF-I signaling, leading to increased myoblast cell proliferation and migration. To determine the significance of these actions in vivo and to evaluate if they are physiologically beneficial, EA and EB were expressed in murine skeletal muscle via viral vectors. The viral constructs ensured production of E-peptides without the influence of additional IGF-I through an inactivating mutation in mature IGF-I. E-peptide expression altered ERK1/2 and Akt phosphorylation and increased satellite cell proliferation. EB expression resulted in significant muscle hypertrophy that was IGF-I receptor dependent. However, the increased mass was associated with a loss of muscle strength. EA and EB have similar effects in skeletal muscle signaling and on satellite cells, but EB is more potent at increasing muscle mass. Although sustained EB expression may drive hypertrophy, there are significant physiological consequences for muscle.
Author Brisson, Becky K
Spinazzola, Janelle
Barton, Elisabeth R
Park, SooHyun
Author_xml – sequence: 1
  givenname: Becky K
  surname: Brisson
  fullname: Brisson, Becky K
  organization: Department of Anatomy and Cell Biology, School of Dental Medicine, and Pennsylvania Muscle Institute, University of Pennsylvania, Philadelphia, Pennsylvania
– sequence: 2
  givenname: Janelle
  surname: Spinazzola
  fullname: Spinazzola, Janelle
– sequence: 3
  givenname: SooHyun
  surname: Park
  fullname: Park, SooHyun
– sequence: 4
  givenname: Elisabeth R
  surname: Barton
  fullname: Barton, Elisabeth R
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24569593$$D View this record in MEDLINE/PubMed
BookMark eNqNkk9vFCEYh4mpsdvqF_BgSLx4mZX_M1xMTNNqkyZe1CsB5t3d2c7CCIzab1_Gro16Eg6QvA9PeOF3hk5CDIDQS0rWlEr21u4nCH1ckzq6NSNUPEGrWmANlVKeoBWhmje0E_oUneW8r1grBXuGTpmQSkvNV-ju65DsiOHnlCDnIQYcN3gIeR6H0IzDLeBtij_KDm-sLzHha3zZTDCVoYdcOZ_A5rrLtzBCqaLDnP0I-GBzxm4u2BZcdrD4IWRY5LkkCNuye46ebuyY4cVxPUdfri4_X3xsbj59uL54f9N4oXhplLWOeODUtcJT5uoEz9yGKgcd75VV3pO26xioTvteKeqkIsIJp0UvW8fP0bsH7zS7A_QeQqkdmykNB5vuTLSD-bsShp3Zxu-G6063glXBm6MgxW8z5GIOQ_YwjjZAnLOhkotOEs7Ff6C05VoTtqCv_0H3cU6hvsRCacUIJ7RS7IHyKeacYPN4b0rMEgJzDIH5FQKzhKAeevVnx49Hfv86vweWzLMz
CODEN AJPMD9
CitedBy_id crossref_primary_10_3724_abbs_2023086
crossref_primary_10_1017_S0954422423000124
crossref_primary_10_2147_IJGM_S301141
crossref_primary_10_3389_fphys_2018_00999
crossref_primary_10_1016_j_biomaterials_2014_12_050
crossref_primary_10_1016_j_ghir_2016_11_001
crossref_primary_10_1007_s00424_014_1645_5
crossref_primary_10_1016_j_ghir_2014_06_003
crossref_primary_10_1080_10408398_2021_1986466
crossref_primary_10_1111_acel_12954
crossref_primary_10_1152_ajpregu_00230_2015
crossref_primary_10_1016_j_bone_2015_04_036
crossref_primary_10_1002_mus_26641
crossref_primary_10_3389_fphys_2022_1028345
crossref_primary_10_36803_ijpmr_v11i01_328
crossref_primary_10_1016_j_yexcr_2017_06_015
crossref_primary_10_3390_ijms21196995
Cites_doi 10.1073/pnas.0604893104
10.1172/JCI0213503
10.1210/jcem-65-5-868
10.1016/j.febslet.2007.05.030
10.1210/mend-1-3-243
10.1101/gad.908001
10.1096/fj.11-192195
10.1038/84839
10.1152/jappl.1998.84.5.1716
10.1249/00005768-199006000-00006
10.1113/jphysiol.2011.212845
10.1073/pnas.95.26.15603
10.1093/nar/14.20.7873
10.1113/jphysiol.2002.035832
10.1016/S0014-5793(02)02918-6
10.1096/fj.09-131870
10.1038/306609a0
10.1096/fj.11-203026
10.1074/jbc.270.20.12109
10.1016/j.ghir.2008.05.001
10.1152/ajpendo.00408.2013
10.1210/en.2012-1992
10.1016/S0960-8966(00)00192-9
10.1111/j.1600-6143.2007.01927.x
10.1210/mend-4-6-899
10.1152/japplphysiol.01405.2005
10.1371/journal.pone.0045588
10.1089/rej.2007.0597
10.1210/en.2009-1217
10.1113/jphysiol.1988.sp017279
10.1371/journal.pone.0051152
10.1091/mbc.E08-12-1202
10.1152/japplphysiol.01308.2009
10.1055/s-2007-978697
10.1210/me.2004-0409
10.1054/ghir.2000.0182
10.1038/mt.2008.171
10.1210/mend-2-6-528
ContentType Journal Article
Copyright Copyright American Physiological Society Apr 15, 2014
Copyright © 2014 the American Physiological Society 2014 American Physiological Society
Copyright_xml – notice: Copyright American Physiological Society Apr 15, 2014
– notice: Copyright © 2014 the American Physiological Society 2014 American Physiological Society
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QP
7TS
7U7
C1K
7X8
7U9
H94
5PM
DOI 10.1152/ajpendo.00008.2014
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Calcium & Calcified Tissue Abstracts
Physical Education Index
Toxicology Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Toxicology Abstracts
Calcium & Calcified Tissue Abstracts
Physical Education Index
Environmental Sciences and Pollution Management
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
DatabaseTitleList Toxicology Abstracts
MEDLINE
AIDS and Cancer Research Abstracts
CrossRef

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1555
EndPage E974
ExternalDocumentID 3288104861
10_1152_ajpendo_00008_2014
24569593
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: R01 AR057363
– fundername: NIAMS NIH HHS
  grantid: AR-057363
– fundername: NIAMS NIH HHS
  grantid: AR-053461
GroupedDBID ---
23M
2WC
39C
4.4
53G
5GY
5VS
6J9
AAFWJ
ABJNI
ACPRK
ADBBV
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKOMP
BTFSW
CGR
CUY
CVF
DIK
E3Z
EBS
ECM
EIF
EJD
EMOBN
F5P
GX1
H13
ITBOX
KQ8
NPM
OK1
P2P
P6G
PQQKQ
RAP
RHF
RHI
RPL
RPRKH
TR2
W8F
WH7
WOQ
XSW
YSK
AAYXX
CITATION
7QP
7TS
7U7
C1K
7X8
7U9
H94
5PM
ID FETCH-LOGICAL-c463t-6aab0ce31b74c12b2b2ec2bf16be83d6a6cc07882e689cd661b5604b4b94d57b3
ISSN 0193-1849
IngestDate Tue Sep 17 21:26:51 EDT 2024
Fri Oct 25 06:24:18 EDT 2024
Fri Oct 25 23:49:47 EDT 2024
Thu Oct 10 16:45:00 EDT 2024
Thu Sep 12 17:24:48 EDT 2024
Sat Sep 28 08:02:29 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords adeno-associated viral vectors
IGF-I
E-peptides
skeletal muscle
hypertrophy
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c463t-6aab0ce31b74c12b2b2ec2bf16be83d6a6cc07882e689cd661b5604b4b94d57b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://europepmc.org/articles/pmc3989742
PMID 24569593
PQID 1519620301
PQPubID 48583
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3989742
proquest_miscellaneous_1534850334
proquest_miscellaneous_1517399024
proquest_journals_1519620301
crossref_primary_10_1152_ajpendo_00008_2014
pubmed_primary_24569593
PublicationCentury 2000
PublicationDate 2014-04-15
PublicationDateYYYYMMDD 2014-04-15
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda
– name: Bethesda, MD
PublicationTitle American journal of physiology: endocrinology and metabolism
PublicationTitleAlternate Am J Physiol Endocrinol Metab
PublicationYear 2014
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
References 6358902 - Nature. 1983 Dec 8-14;306(5943):609-11
3253447 - J Physiol. 1988 Oct;404:71-82
11297941 - Neuromuscul Disord. 2001 Apr;11(3):260-8
19661286 - FASEB J. 2009 Nov;23(11):3896-905
24371018 - J Appl Physiol (1985). 2014 Apr 1;116(7):797-806
23407283 - J Vis Exp. 2013;(71):e50036
8897022 - Endocr Rev. 1996 Oct;17(5):481-517
17531227 - FEBS Lett. 2007 Jun 12;581(14):2727-32
24253050 - Am J Physiol Endocrinol Metab. 2014 Jan 15;306(2):E150-6
23029120 - PLoS One. 2012;7(9):e45588
23407451 - Endocrinology. 2013 Mar;154(3):1215-24
17822355 - Rejuvenation Res. 2007 Sep;10(3):397-405
22649033 - FASEB J. 2012 Sep;26(9):3691-702
3453891 - Mol Endocrinol. 1987 Mar;1(3):243-8
16439513 - J Appl Physiol (1985). 2006 Jun;100(6):1778-84
12692175 - J Physiol. 2003 Jun 1;549(Pt 2):409-18
15576456 - Mol Endocrinol. 2005 Mar;19(3):711-21
19567392 - In Vivo. 2009 Jul-Aug;23(4):567-75
22125316 - FASEB J. 2012 Mar;26(3):1077-85
18571449 - Growth Horm IGF Res. 2009 Feb;19(1):12-23
9572822 - J Appl Physiol (1985). 1998 May;84(5):1716-22
11437469 - Growth Horm IGF Res. 2001 Feb;11(1):10-7
11827994 - J Clin Invest. 2002 Feb;109(3):347-55
12095637 - FEBS Lett. 2002 Jul 3;522(1-3):156-60
20130113 - Endocrinology. 2010 Mar;151(3):865-75
23251442 - PLoS One. 2012;7(12):e51152
10226780 - Horm Metab Res. 1999 Feb-Mar;31(2-3):43-9
8402901 - Cell. 1993 Oct 8;75(1):59-72
11175789 - Nat Genet. 2001 Feb;27(2):195-200
21807613 - J Physiol. 2011 Oct 1;589(Pt 19):4759-76
3774549 - Nucleic Acids Res. 1986 Oct 24;14(20):7873-82
18682697 - Mol Ther. 2008 Oct;16(10):1648-56
20133429 - J Appl Physiol (1985). 2010 May;108(5):1069-76
18396778 - In Vivo. 2008 Jan-Feb;22(1):27-35
3419435 - Mol Endocrinol. 1988 Jun;2(6):528-35
17267614 - Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1835-40
17845560 - Am J Transplant. 2007 Oct;7(10):2247-59
19605562 - Mol Biol Cell. 2009 Sep;20(17):3810-7
7744859 - J Biol Chem. 1995 May 19;270(20):12109-16
9861016 - Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15603-7
11485987 - Genes Dev. 2001 Aug 1;15(15):1926-34
2233747 - Mol Endocrinol. 1990 Jun;4(6):899-904
3312279 - J Clin Endocrinol Metab. 1987 Nov;65(5):868-75
2199752 - Med Sci Sports Exerc. 1990 Jun;22(3):304-11
B20
B42
B43
B22
B44
B23
B24
B25
B26
B28
B29
Philippou A (B38) 2008; 22
B30
B31
B10
B32
B11
Moorwood C (B33) 2013
B12
B34
B13
B14
B36
B15
B16
B17
B39
B18
B19
Florini JR (B21) 1996; 17
Liu JP (B27) 1993; 75
B1
B2
B3
B4
B5
Philippou A (B37) 2009; 23
B6
B7
B8
B9
Park S (B35) 2013
B40
B41
References_xml – ident: B3
  doi: 10.1073/pnas.0604893104
– ident: B19
  doi: 10.1172/JCI0213503
– start-page: e50036
  year: 2013
  ident: B33
  publication-title: J Vis Exp
  contributor:
    fullname: Moorwood C
– ident: B39
  doi: 10.1210/jcem-65-5-868
– ident: B4
  doi: 10.1016/j.febslet.2007.05.030
– ident: B41
  doi: 10.1210/mend-1-3-243
– ident: B20
  doi: 10.1101/gad.908001
– ident: B40
  doi: 10.1096/fj.11-192195
– ident: B34
  doi: 10.1038/84839
– year: 2013
  ident: B35
  publication-title: J Appl Physiol (1985)
  contributor:
    fullname: Park S
– ident: B1
  doi: 10.1152/jappl.1998.84.5.1716
– ident: B2
  doi: 10.1249/00005768-199006000-00006
– ident: B6
  doi: 10.1113/jphysiol.2011.212845
– ident: B10
  doi: 10.1073/pnas.95.26.15603
– ident: B11
  doi: 10.1093/nar/14.20.7873
– ident: B25
  doi: 10.1113/jphysiol.2002.035832
– ident: B44
  doi: 10.1016/S0014-5793(02)02918-6
– ident: B12
  doi: 10.1096/fj.09-131870
– ident: B26
  doi: 10.1038/306609a0
– ident: B9
  doi: 10.1096/fj.11-203026
– ident: B15
  doi: 10.1074/jbc.270.20.12109
– ident: B42
  doi: 10.1016/j.ghir.2008.05.001
– volume: 17
  start-page: 481
  year: 1996
  ident: B21
  publication-title: Endocr Rev
  contributor:
    fullname: Florini JR
– ident: B22
  doi: 10.1152/ajpendo.00408.2013
– ident: B18
  doi: 10.1210/en.2012-1992
– ident: B29
  doi: 10.1016/S0960-8966(00)00192-9
– ident: B32
  doi: 10.1111/j.1600-6143.2007.01927.x
– ident: B5
  doi: 10.1210/mend-4-6-899
– ident: B7
  doi: 10.1152/japplphysiol.01405.2005
– ident: B13
  doi: 10.1371/journal.pone.0045588
– ident: B23
  doi: 10.1089/rej.2007.0597
– volume: 75
  start-page: 59
  year: 1993
  ident: B27
  publication-title: Cell
  contributor:
    fullname: Liu JP
– ident: B30
  doi: 10.1210/en.2009-1217
– ident: B14
  doi: 10.1113/jphysiol.1988.sp017279
– ident: B24
  doi: 10.1371/journal.pone.0051152
– ident: B36
  doi: 10.1091/mbc.E08-12-1202
– volume: 22
  start-page: 27
  year: 2008
  ident: B38
  publication-title: In Vivo
  contributor:
    fullname: Philippou A
– ident: B8
  doi: 10.1152/japplphysiol.01308.2009
– ident: B17
  doi: 10.1055/s-2007-978697
– ident: B16
  doi: 10.1210/me.2004-0409
– ident: B43
  doi: 10.1054/ghir.2000.0182
– ident: B31
  doi: 10.1038/mt.2008.171
– volume: 23
  start-page: 567
  year: 2009
  ident: B37
  publication-title: In Vivo
  contributor:
    fullname: Philippou A
– ident: B28
  doi: 10.1210/mend-2-6-528
SSID ssj0007542
Score 2.2675142
Snippet Insulin-like growth factor I (IGF-I) is a protein that regulates and promotes growth in skeletal muscle. The IGF-I precursor polypeptide contains a...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage E965
SubjectTerms 3T3 Cells
Animals
Cellular biology
Dependovirus
Gene Transfer Techniques
Genetic Vectors
Human growth
Insulin-Like Growth Factor I - genetics
Insulin-like growth factors
Mice
Mice, Inbred C57BL
Muscle Strength - genetics
Muscle, Skeletal - anatomy & histology
Muscle, Skeletal - metabolism
Musculoskeletal system
Organ Size - genetics
Peptide Fragments - genetics
Phosphorylation
Physiology
Protein expression
Title Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength
URI https://www.ncbi.nlm.nih.gov/pubmed/24569593
https://www.proquest.com/docview/1519620301
https://search.proquest.com/docview/1517399024
https://search.proquest.com/docview/1534850334
https://pubmed.ncbi.nlm.nih.gov/PMC3989742
Volume 306
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF5FRUK8IGg5AgUtEuIlMjS-_diiVCm05UpQ3yzv4SYksSNiSyT_mn_AzO76CEEVoEiWZa-8m53PszPrb2YIeRmCjksi4Vu-5KnlMtuxIltwC1ZmMJaTVHKBgcIXl_5w7L678q46nZ8t1lJZsNd888e4kv-RKlwDuWKU7D9Itn4oXIBzkC8cQcJw_CsZf51ieL38Ycismc7_oMjl1nw6k71rcLKLiSmq0zvrDawlsliEYmGhvbiCs9UMlh6MiVyUK-igtwB7usfKKs5RFQHI9JY_RpZk18WkbdLW33xaSSjUfomOg8HKP5nIQTllTbqnBfTH8nmVvlBtBwACNAPgRPLZurX9upxmyWYDLrhm9SIvp0bjR0P1_pLnw3VZA_0EJssUKZljEmEJk_C5vcHRV7wYHeLZiinAFaEaukKvIbW2t0YjxwJ_VStgadQ5uNpgMXltfe8c-S1ghy3tPYh03YrdZcXDNLXJNyxLnKuUl4oV6DaLaEUcuPwQn47Pz-PR4Gq0fVfbDHYY9jHLITjst2zQjaiU339qEtxjQWId4a__TBXn5dlvdrvftqV2HKTfeb4tw2l0j9w1Hg891vC9Tzoy2ycHx1lS5Is1fUXrCV_vk9sXhupxQNYK3LQBN81T2gY31eCmGtz0jDbgpjW4aQVuqsFNEdwUwE2TggK4qQE3PrwC9wMyPh2M3g4tUyfE4q7vFJafJOyIS6fPApf3bQY_yW2W9n0mQ0f4ic85WMKhLf0w4gIsUgZ2vstcFrnCC5jzkOxleSYfE8oj37aFYGkCpjoPolA6zBFSeFHqgKvBu6RXzXi81OlgYuVGe3Zs5BMr-cQony45rIQSm3dwFYOJDZ3gTkSXvKhvg1LHL3XwDuWlahOA5wD2801tHDdEEgK0eaTlXA8J2QyYcbxLgi0E1A0wqfz2nWw6UcnlnSiMAtd-cvPQn5I7zat6SPaK76V8BtZ5wZ4rPP8CPpXxPg
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral+expression+of+insulin-like+growth+factor+I+E-peptides+increases+skeletal+muscle+mass+but+at+the+expense+of+strength&rft.jtitle=American+journal+of+physiology%3A+endocrinology+and+metabolism&rft.au=Brisson%2C+Becky+K&rft.au=Spinazzola%2C+Janelle&rft.au=Park%2C+SooHyun&rft.au=Barton%2C+Elisabeth+R&rft.date=2014-04-15&rft.pub=American+Physiological+Society&rft.issn=0193-1849&rft.eissn=1522-1555&rft.volume=306&rft.issue=8&rft.spage=E965&rft_id=info:doi/10.1152%2Fajpendo.00008.2014&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3288104861
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0193-1849&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0193-1849&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0193-1849&client=summon